Generic Manufacturer Reduces Time-to-Market by 40%
Case study on how streamlined CDMO partnership cut development timelines.
1 min read907 viewsPublished July 20, 2025
Generic Manufacturer Reduces Time-to-Market by 40%
Company Profile
A mid-sized generic pharmaceutical company needed to accelerate its product launch pipeline.
Initial Situation
- Average development timeline: 36 months
- Multiple CDMO relationships causing coordination issues
- Inconsistent quality outcomes
Strategic Initiative
Consolidated CDMO Strategy
- Reduced CDMOs from 12 to 4 strategic partners
- Established master service agreements
- Created joint governance committees
Process Standardization
- Unified technology transfer protocols
- Standardized analytical method transfer
- Common quality agreement template
Results
- Development timeline reduced to 22 months average
- 30% reduction in project management costs
- 15% improvement in first-time-right manufacturing
Success Factors
- Executive sponsorship from both sides
- Clear communication protocols
- Shared performance metrics
Was this article helpful?
Sign in to provide feedback